

Dr. Sam Azoulay is the Senior Vice President, Medical & Development, of the Emerging Markets and Established Products Business Units for Pfizer Inc. Dr. Azoulay joined Pfizer as a result of the company’s acquisition of Parke Davis, Warner Lambert in 2000, where h…more ›
Dr. Zhang is the Vice President of medical affairs, clinical development and regulatory affairs for the great China region of Novo Nordisk, he has more than 10 years experience in R&D and commercial function of pharmaceutical industry. Prior to the current position …more ›

A qualified Medical professional from Mumbai, India having completed his under-graduate education (MBBS) from T N Medical College and B Y L Nair Charitable Hospital and post-graduation (MD – Pharmacology) from Grant Medical College and Sir JJ Group of Hospitals, both re…more ›

Dr. Mu joined Hutchison MediPharma in 2010 as the Senior Vice President, Clinical Research & Development. He has over 16 years of clinical research and development experience focusing on oncology, having held medical and clinical leadership positions at several lea…more ›

Jeffrey S. Kasher, Ph.D., was named vice president and chief operating officer, global clinical development for Eli Lilly and Company in February 2007. He received a bachelor of science degree in chemistry from Franklin & Marshall College (Lancaster, Pa), a doctor…more ›

Dr Choe is a highly accomplished medical director with over 9 years of experience at MSD Korea, sanofi-aventis Korea, Wyeth Korea and Pfizer Korea. He is an expert in leading and contributing in cross functional and global projects. In addition, he actively engages the …more ›

Joseph was born and raised in the Netherlands and studied pharmacy at the University of Leiden from 1974-1982. Joseph started in the pharmaceutical industry with Servier in Paris (France) in 1982 and was responsible for regulatory affairs Northern and Eastern Europe. J…more ›

Mr. Tetsuomi Takano graduated from the Faculty of Pharmaceutical Sciences of the Tokyo University of Science and joined former Yamanouchi (current Astellas) Pharma in 1986. He moved to the Development Division and started to become responsible for many development proje…more ›

Dr. Luk joined Biogen Idec’s hemophilia therapeutic area in 2009, from Bayer Healthcare, Bayer Schering Pharma where he was Deputy Director, Global Clinical Program & Resource Management, with specific emphasis on hemophilia. He has more than 15 years of distinguish…more ›

Dr. Werner Katzmann holds an MD and a PhD from the University of Tübingen, Germany. In April 2011, Werner joined Biogen Idec as the Senior Director of Regional Medical Affairs for Asia Pacific. In this position, he is building up a medical and scientific infrastruc…more ›

Dr. Christopher Fang brings a wealth of experience in both medical device and pharmaceutical industries. He has worked to improve healthcare through innovation in biomedical technology. Dr. Fang serves as the Worldwide Director of Clinical Research and Medical Affair…more ›

Krisztina is presently Group Director of Regulatory Affairs for Asia-Pacific Region with responsibilities for Australia, Hong Kong, Korea, Singapore, Taiwan, and Thailand at Bristol Myers Squibb Company (BMS). She is responsible for partnering effectively with the com…more ›

Patrecia Valone, Director for Development Operations at Takeda Global Research & Development (TGRD) Asia in Singapore has over 19 years of experience in Clinical Research across a variety of therapeutic areas. Ms Valone received her Bachelors’ and Masters’ degree i…more ›

Dr. Chang is currently the Medical Director at Abbott Laboratories responsible for the territories of Taiwan and South Korea where she leads the Affiliate Medical Department Team and the Medical Department. In her current role, Dr. Chang sets the vision and direction fo…more ›

Dr Trang Nguyen Hoang Hanh has been appointed Head of Medical Affair and Clinical Operations in Sanofi Vietnam since 2008 after 3 years of experience in Clinical Study and Health Economics. In this position, she has made substantial contributions in developing the clini…more ›

Mr Kim is the director of the Clinical Trials Management Division, Risk Prevention Policy Bureau, KFDA. In this division he is in charge of policies related to clinical trials of drugs, medical devices, laboratory animals and experimental animal laboratories. He also ha…more ›

Bhavani has over 18 years working experience in Clinical Research, the last 14 years with Quintiles East Asia Pte Ltd, managing multi-national studies across Asia, Europe, North America & Latin America. She has significant experience working in cardiology, oncology …more ›

As Vice President of Global Partnerships and Alliances at Medidata Solutions, Graham coordinates and manages contract research organizations and other service delivery organizations in the training, sales and delivery of Medidata products and services enabling Partners …more ›

Malcolm relocated to Hong Kong early in 2011 to take up the role of Executive Vice President with special responsibility for the growth and development Asia Pacific. Previously he was responsible for our Global Clinical Research strategy during which time he focused on …more ›
Currently Director of Regulatory Affairs Asia Pacific for ReSearch Pharmaceutical Services, Andrew has worked in the pharmaceutical industry for 23 years, with 18 years in the field of Regulatory Affairs preceded by 5 years in vaccine manufacturing roles. His regulator…more ›

Manish is one of the few Qualified Radiologist with more than 11 years rich experience in Academia & Clinical Research. He has significant experience working in oncology, cardiology, musculoskeletal & central nervous system, specifically global trials with surro

E. Stewart Geary, M.D, has worked at Eisai since 1996 in pharmacovigilance, clinical safety and regulatory science. He is currently a member of the CIOMS IX Working Group on Medicinal Product Risk Management, the Executive Committees of the Japanese Association of Pharm…more ›
Helen Han Hsu is presently Vice President, Head of Drug Safety Sciences, Asia Pacific and Global Head of Business Development at Janssen Pharmaceutical Research and Development, a member of Johnson and Johnson Companies. Her 13 years tenure with Johnson and Johnson als…more ›

Dr. Vivek (Vic) Kadambi is the head of the Drug Safety & Evaluation Group at Millennium: The Takeda Oncology Company. Dr. Kadambi has a B.S. and a M.S. in Microbiology from the University of Bombay and a Ph.D. in Cardiovascular Pharmacology and Physiology from the …more ›
Pharma Trials World Asia 2012 is the meeting place for all global and Asian pharmas, biotechs, CROs, regulators, hospitals, and clinical trial solution providers to discuss about best strategies in fast-tracking clinical trial drug developments in Asia. Attended by Asia's top 50 pharma companies and supported by leading clinical trial players from all across the world, this event is a must attend for all who are interested to advance their clinical trial operations and meet face-to-face with senior level decision makers of Asia's clinical trial industry. Co-located with BioPharma Asia Convention, this is the event not to be missed for all stakeholders in the clinical trial space.